The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis

• Published in: Journal of psychiatric research Vol. 106; pp. 43 - 53
• Main Authors: Rodrigues-Amorim, Daniela, Rivera-Baltanás, Tania, Bessa, João, Sousa, Nuno, Vallejo-Curto, María de Carmen, Rodríguez-Jamardo, Cynthia, de las Heras, María Elena, Díaz, Roberto, Agís-Balboa, Roberto Carlos, Olivares, J.M., Spuch, Carlos
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.11.2018
• ISSN: 0022-3956; 1879-1379
• DOI: 10.1016/j.jpsychires.2018.09.007

Schizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known to contribute to the disease pathology. One potential contributor is the family of neurotrophins which are proteins involved in multiple functional processes in the nervous system, with crucial roles in neurodevelopment, synaptogenesis and neuroplasticity. With these roles in mind, abnormal neurotrophin profiles have been hypothesized to contribute to the pathology of schizophrenia. We performed a systematic review and a meta-analysis to scrutinize the neurobiological hypothesis of neurotrophins in schizophrenia, examining the correlation between peripheral levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3) and neurotrophin 4/5 (NT-4/5) associated with schizophrenia. Fifty-two studies were reviewed and twenty-two studies were included in this meta-analysis. Using a random effects model, we confirmed that decreased levels of neurotrophins (BDNF, NGF and NT-4/5) were associated with schizophrenia (Hedges's g = −0.846; SE = 0.058; 95% confidence interval: −0.960 to −0.733; Z-value = −14.632; p-value = 0.000). Subgroup analysis indicated that neurotrophin levels are significantly decreased in both medicated and drug-näive patients. Meta-regression of continuous variables such as mean age, duration of illness and PANSS total score did not show significant effects (p > 0.05) in relation to neurotrophins levels. We confirm that decreased peripheral neurotrophin levels are significantly associated with schizophrenia, thereby confirming the neurobiological hypothesis of neurotrophins in schizophrenia. Low levels of neurotrophins in peripheral blood of patients with schizophrenia may explain, in part, the pathophysiology of schizophrenia. •Neurotrophins are associated with the pathophysiology of schizophrenia.•Patients with schizophrenia have decreased levels of neurotrophins.•Peripheral levels of neurotrophins contribute to the neurobiological hypothesis of schizophrenia.